Merck sales slump again, but cost cuts keep earnings coming

Tracy Staton On the Big Pharma scorecard, Merck remains on a downward slide. Yes, third-quarter earnings beat estimates, but expectations were low, and it was cost-cutting that delivered ...

Humira sales, up 19%, continue to carry AbbVie

Eric Palmer What is better than having the best-selling drug in the world.? Having the best-selling drug and seeing its sales sprint ahead by more than 19% for a quarter. FiercePharma ...

Biogen’s Tecfidera snaps up managed care coverage en route to blockbuster sales

Carly Helfand Biogen Idec's MS pill Tecfidera has had no problem taking the market by storm since its launch in April. And armed with new reimbursement data, analysts now say more ...

Bristol-Myers scores with cancer, diabetes sales hikes

Tracy Staton Bristol-Myers Squibb's third-quarter results amount to a good-news, bad-news report. On the positive side, international sales were up 18%, driving an overall increase ...

GlaxoSmithKline’s India sales bashed by pricing protest

Carly Helfand Drugmakers weren't exactly thrilled last year when Indian ministers nearly quintupled the list of drugs subject to government price controls. As it turns out, neither ...

Merck KGaA eyes KRAS-gene focus to boost Erbitux sales

Carly Helfand In an interview with Reuters, Belén Garijo, head of the company's pharma unit Merck Serono, outlined a strategy for Erbitux centered on the KRAS mutation-free ...

Lilly warns of ‘challenging’ bid for 2014 sales goal, thanks to yen, emerging markets

Tracy Staton Meeting next year's minimum revenue goal of $ 20 billion will be "challenging," Eli Lilly says, and analysts are already speculating about "savage" ...

Eli Lilly’s diabetes strategy doesn’t include big staff-up in sales

Tracy Staton As Lilly Diabetes President Enrique Conterno tells Bloomberg, the company plans to lean on its broad product portfolio to grow sales, rather than sending out legions of ...

Are side effects warnings good for sales? In TV ads, yes

Tracy Staton This is either a story about the virtues of honesty or the ever-changing minds of the American consumer. That litany of drug side-effects that's delivered rapid-fire ...

Training Execs from Top Medical Device and Diagnostic Companies to Host Annual Medical Sales Trainer Summit

barbara.lempert Event topics will focus on ACA, Learning Metrics and ROI, Patient and Product Outcomes, e-Learning, mHealth, Global Sales Education, and the role of Sales Trainers ROANOKE, ...

Forest hits setback on new COPD drug, one of its key hopes for sales growth

Tracy Staton The delay could interfere with their plans to compete against rival drugs that could get to market first. FiercePharma News

Report: Humira Climbs into Top 5 in Q2 Drug Sales

barbara.lempert Drugs.com Releases Q2 Sales for Top 100 U.S. Prescription Drugs: Humira Climbs into Top 5 and Posts Double-Digit Growth NEW YORK, Aug. 14, 2013 /PRNewswire/ ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS